ME
Therapeutic Areas
Verdiva Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| VRB-101 (Oral) | Obesity | Phase 2 |
| VRB-103 (Oral) | Obesity | Preclinical |
| VRB-101 + VRB-103 (Oral) | Obesity | Preclinical |
| VRB-101 + VRB-102 (Injectable) | Obesity | Preclinical |
| VRB-104 | Undisclosed | Preclinical |